News

News

Dr Kirsten Fairfax pipetting in the laboratory

A good immune system relies on a key ‘energy producing’ protein in immune cells to develop immunity to vaccines and disease, an international team of scientists has found.

6 March 2015
Professor Jane Visvader and Dr Nai Yang Fu working in the laboratory

Australian researchers have discovered the protein MCL-1 is critical for keeping milk-producing cells alive and sustaining milk production in the breast.

3 March 2015
Associate Professor Mike Lawrence working in the lab

Melbourne scientists now have access to an unparalleled view of the molecular world thanks to Australia's first advanced structural cryo-electron microscopy centre.

2 February 2015
Dr Axel Kallies and Dr Ajith Vasanthakumar in the laboratory

Preventing inflammation in obese fat tissue may hold the key to preventing or even reversing type 2 diabetes, new research has found.

28 January 2015
Venture Grants research team

Walter and Eliza Hall Institute scientists have been awarded $1 million for a ‘visionary’ project to identify the key cancer-causing genes that trigger leukaemia, lymphoma and breast cancer development.

20 January 2015
MCL-1 team in the laboratory

Melbourne researchers have discovered that targeting a cell ‘survival’ protein could help treat some lymphomas, including those cancers with genetic defects that make them resistant to many existing therapies.

13 January 2015
Ms Julia Marchingo working in the lab

Ms Julia Marchingo, a PhD student at the Walter and Eliza Hall Institute and The University of Melbourne, has won a 2014 Picchi Award for Excellence in Cancer Research.

22 December 2014
Dr Michael White in a laboratory

Walter and Eliza Hall Institute researchers have for the first time revealed how dying cells are hidden from the immune ‘police’ that patrol the body.

18 December 2014
Professor Don Metcalf stands in his office with a lab notebook

It is with great sadness that we announce the death of Professor Donald Metcalf AC, an outstanding medical researcher whose discovery of colony stimulating factors has benefited more than 20 million people worldwide.

15 December 2014
Dr Marc Pellegrini and Dr Greg Ebert in a laboratory

A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus (HBV) infection is now recruiting patients for a phase I/2a clinical trial.

15 December 2014

Pages